By Don Dion:
Diplomat Pharmacy (Pending:DPLO), the nation’s biggest independent specialty pharmacy that focuses on individuals with complex chronic diseases, plans to raise up to $245,333,328 in its upcoming IPO.
The Flint, Michigan based company will offer 13,333,333 shares at an expected price range of $14 to $16.
DPLO filed on July 3, 2014.
Lead Underwriters: Credit Suisse Securities, Morgan Stanley